Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Cancer prevention has advanced significantly, with some strategies proving successful.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.